Organon & Co. - Common Stock (OGN)

Q4 2024 13F Holders as of 12/31/2024

Type / Class
Equity / Common Stock
Shares outstanding
260M
Number of holders
708
Total 13F shares, excl. options
206M
Shares change
+6.07M
Total reported value, excl. options
$3.07B
Value change
+$45.5M
Put/Call ratio
0.7
Number of buys
270
Number of sells
-336
Price
$14.92

Significant Holders of Organon & Co. - Common Stock (OGN) as of Q4 2024

826 filings reported holding OGN - Organon & Co. - Common Stock as of Q4 2024.
Organon & Co. - Common Stock (OGN) has 708 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 206M shares of 260M outstanding shares and own 79.09% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (32.8M shares), VANGUARD GROUP INC (30.4M shares), Pacer Advisors, Inc. (11.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (9.9M shares), STATE STREET CORP (9.34M shares), LSV ASSET MANAGEMENT (7.53M shares), NORDEA INVESTMENT MANAGEMENT AB (6.74M shares), SOUND SHORE MANAGEMENT INC /CT/ (4.97M shares), DEPRINCE RACE & ZOLLO INC (4.73M shares), and MORGAN STANLEY (4.55M shares).
This table shows the top 708 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.